Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 378

B Capital captures $820m for second fund

The venture firm, which is partners with Boston Consulting Group, said it now has in excess of $1.4bn of assets under management.

Jul 2, 2020

Bolt Biotherapeutics latches onto series C financing

Novo, Pfizer and Nan Fung helped provide $93.5m for the cancer treatment developer as it advances its lead product candidate towards the clinic.

Jul 2, 2020

Away packs up bridge financing

Comcast Ventures-backed smart luggage brand Away has reportedly secured $30m to $40m in bridge financing as it faces a downturn in business due to the coronavirus.

Jul 2, 2020

Mynd houses series C funding

Wells Fargo led a $41.5m round for the tech-equipped property manager that included existing backers Canaan Partners, Lightspeed Venture Partners and Jackson Square Ventures.

Jul 2, 2020

Elementary elects to close series A round

Returning investor Toyota AI Ventures chipped in as smart manufacturing technology producer Elementary Robotics closed a $12.7m round.

Jul 1, 2020

Shift gears up for reverse merger

The Lithia Motors, BMW and Alliance Ventures-backed automotive e-commerce marketplace is set to go public through a reverse merger with Insurance Acquisition.

Jul 1, 2020

Workday exits as Integris enters OneTrust

OneTrust has acquired private data software provider Integris, which had previously raised some $22m in funding from investors including Workday Ventures.

Jul 1, 2020

Mirror reflects on $500m acquisition

At-home fitness company Mirror is set to be acquired by Lululemon for $500m, after the corporate contributed to its series B round in November.

Jul 1, 2020

Coty cuts off $200m for KKW investment

The beauty and cosmetics group is acquiring a 20% stake in Kim Kardashian West's beauty brand at a $1bn valuation in connection with a partnership agreement.

Jul 1, 2020

Goldfinch Bio holds on to $100m

Existing backer Gilead Sciences returned for a series B round that boosted the kidney disease therapy developer's total funding to $160m.

Jul 1, 2020

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here